Development of a Public Database on Biotech Companies Using AI
The current version of the database, as reported by XXX, is in excellent shape and ready for use by the YYY community. I propose we make this database public while simultaneously working on Version 2 (V2) to support broader access and engagement.
Vision for V2 Development
The goal of V2 is to build on the existing structure by:
Expanding the number of companies listed
Updating and enriching information on current entries
Tailoring data collection through feedback from the Bits in Bio users community
Launching monthly surveys (initially) and later shifting to a quarterly cadence to guide content updates
On Peer Review
While I see the long-term value in peer reviewing, I am cautious about implementing it at this stage due to its resource-intensive nature. I recommend we take an iterative approach and consider introducing peer review in V4. Key concerns to address before launching peer review include:
Defining transparent evaluation criteria for reviewers to ensure consistency and reduce bias
Accounting for the dynamic nature of startups (e.g., funding, trials, partnerships) in the review structure
Identifying ways to incentivize reviewers, possibly through recognition
Deciding whether reviews should be anonymous or public, weighing the risks, especially for early-career professionals
Exploring funding opportunities, potentially through partnerships with VC funds, to support this process without burdening the Bits in Bio team
Immediate Next Steps
Launch a dedicated Slack channel focused on AI and life sciences companies
Share the current database widely to raise awareness and encourage engagement
Assess user interest and develop key personas (e.g., VCs, job seekers) to guide feature prioritization
Identify technical requirements for further development and recruit volunteers with relevant expertise, such as upvoting and downvoting companies
Explore funding sources to support ongoing development
As an alternative to peer reviews, I propose V3 to include brief founder interviews covering:
Current pipeline
Five-year vision
Unique value proposition and problem addressed
